These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26424697)

  • 1. Sublethal vancomycin-induced ROS mediating antibiotic resistance in Staphylococcus aureus.
    Li GQ; Quan F; Qu T; Lu J; Chen SL; Cui LY; Guo DW; Wang YC
    Biosci Rep; 2015 Sep; 35(6):. PubMed ID: 26424697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus infection induced redox signaling and DNA fragmentation in T-lymphocytes: possible ameliorative role of nanoconjugated vancomycin.
    Chakraborty SP; Das S; Chattopadhyay S; Tripathy S; Dash SK; Pramanik P; Roy S
    Toxicol Mech Methods; 2012 Apr; 22(3):193-204. PubMed ID: 22074192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.
    Wootton M; Howe RA; Hillman R; Walsh TR; Bennett PM; MacGowan AP
    J Antimicrob Chemother; 2001 Apr; 47(4):399-403. PubMed ID: 11266410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus.
    Howe RA; Wootton M; Walsh TR; Bennett PM; MacGowan AP
    J Antimicrob Chemother; 1999 Nov; 44(5):675-8. PubMed ID: 10552985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials.
    Nguyen A; Roy JJS; Kim JH; Yun KH; Lee W; Kim KK; Kim T; Chaurasia AK
    J Microbiol; 2024 Jul; 62(7):535-553. PubMed ID: 38814539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vancomycin-resistant Staphylococcus aureus].
    Rodríguez CA; Vesga O
    Biomedica; 2005 Dec; 25(4):575-87. PubMed ID: 16433184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
    Cui L; Tominaga E; Neoh HM; Hiramatsu K
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1079-82. PubMed ID: 16495273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
    Chen CJ; Lin MH; Shu JC; Lu JJ
    J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide mediated Staphylococcus aureus pathogenesis and protective role of nanoconjugated vancomycin.
    Chakraborty SP; Mahapatra SK; Sahu SK; Chattopadhyay S; Pramanik P; Roy S
    Asian Pac J Trop Biomed; 2011 Apr; 1(2):102-9. PubMed ID: 23569737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
    Moise PA; North D; Steenbergen JN; Sakoulas G
    Lancet Infect Dis; 2009 Oct; 9(10):617-24. PubMed ID: 19778764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
    Hiramatsu K
    Lancet Infect Dis; 2001 Oct; 1(3):147-55. PubMed ID: 11871491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
    Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
    Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections.
    Holmes NE; Johnson PD; Howden BP
    J Clin Microbiol; 2012 Aug; 50(8):2548-52. PubMed ID: 22593595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.
    Ishii K; Tabuchi F; Matsuo M; Tatsuno K; Sato T; Okazaki M; Hamamoto H; Matsumoto Y; Kaito C; Aoyagi T; Hiramatsu K; Kaku M; Moriya K; Sekimizu K
    Sci Rep; 2015 Nov; 5():17092. PubMed ID: 26603341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ; Tice A
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
    Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.
    Spagnolo AM; Orlando P; Panatto D; Amicizia D; Perdelli F; Cristina ML
    J Prev Med Hyg; 2014 Dec; 55(4):137-44. PubMed ID: 26137787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.